Lenvatinib
Treatment used for 5 conditions
Total Trials
84
Total Participants
18K
Avg Effectiveness
75%
Avg Safety Score
41%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.
Liver cancer due to hepatitis C
Effectiveness:75%
Safety:50%
Trials:30
Participants:8K
Thyroid cancer
Effectiveness:75%
Safety:30%
Trials:36
Participants:5K
Liver cancer due to NASH
Effectiveness:85%
Safety:40%
Trials:5
Participants:2K
Liver cancer due to alcohol use
Effectiveness:60%
Safety:55%
Trials:5
Participants:2K
Liver cancer due to hepatitis B
Effectiveness:80%
Safety:30%
Trials:8
Participants:1K